Mounjaro is a prescription medication for adults with type 2 diabetes used along with diet and exercise to improve blood sugar control. It is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, meaning it activates receptors in the body that help regulate blood sugar and appetite.
Mounjaro is injected weekly under the skin (subcutaneously) and comes in several different doses. It is not insulin but works by increasing insulin release when blood sugar is high, decreasing the amount of sugar your liver makes, and slowing down digestion.
Common side effects include nausea, vomiting, diarrhea, constipation, and stomach pain. Mounjaro is not recommended for people with type 1 diabetes or diabetic ketoacidosis. It is also not approved for weight loss. Important safety information, including the risk of thyroid tumors, is available on the website.